GARG PUSHKAL

PrivateCIK: 1829252
Location

CAMBRIDGE, MA

GARG PUSHKAL (CMO & EVP Dev & Med Affairs) sold 17.3% of their position (4.63K shares) of ALNYLAM PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $1.53M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 5 sales
InsiderGARG PUSHKALCIK 1829252
Officer· CMO & EVP Dev & Med Affairs
Since Dec 2021
-4.63K
Net shares
Net seller
$1.53M
Total sold
5
Open market trades
0B · 5S
7
Total transactions
1.91K acquired · 6.54K disposed
Non-Derivative Transactions6

Common Stock

Direct
M · Option Exercise

Shares

+1.91K

Price / share

Trade value

% of position

7.7%
2/27/2026
24.85K26.76K

Common Stock

Direct
S · Sale

Shares

127.00

Price / share

$328.92

Trade value

$41.77K

% of position

0.5%
2/27/2026
26.76K26.63K

Common Stock

Direct
S · Sale

Shares

2.26K

Price / share

$330.73

Trade value

$747.12K

% of position

8.5%
2/27/2026
26.63K24.37K

Common Stock

Direct
S · Sale

Shares

1.16K

Price / share

$331.49

Trade value

$384.20K

% of position

4.8%
2/27/2026
24.37K23.21K

Common Stock

Direct
S · Sale

Shares

942.00

Price / share

$332.48

Trade value

$313.20K

% of position

4.1%
2/27/2026
23.21K22.27K

Common Stock

Direct
S · Sale

Shares

140.00

Price / share

$334.39

Trade value

$46.81K

% of position

0.6%
2/27/2026
22.27K22.13K
Total

Net shares

2.72K

Net value

-$1.53M

Derivative Transactions1

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

1.91K shares

Shares

1.91K

Strike price

Held after

0.00

Exercisable

2/27/2026
Non-Derivative Holdings (Post-Transaction)2

Common Stock

Indirect
Shares owned250.00

Common Stock

Indirect
Shares owned431.00
Total
681.00 indirect681.00
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
GARG PUSHKAL — Insider Transaction (Form 4) Filed Mar 2, 2026 | Finecho